 Cancer cells exhibit unregulated growth and proliferation due to alterations in metabolic processes. This requires the activation of certain metabolic pathways to support the increased demand for energy and nutrients. The metabolic reprogramming of cancer cells is dynamic and dependent upon the specific tumor type and its environment. It involves multiple metabolic pathways and is driven by the coordinated activity of signaling molecules, proteins and enzymes. This makes cancer cells more resistant to traditional anti-cancer therapies. Recent research has identified metabolic reprogramming as a potential therapeutic target for treating cancer. Understanding the mechanisms behind these metabolic changes could lead to the development of novel treatments for cancer. This article was authored by Shiqinom, Siaya Han, Youxiang and others.